ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Ensysce Biosciences Inc

Ensysce Biosciences Inc (ENSC)

0.65
0.074
(12.85%)
Cerrado 03 Noviembre 3:00PM
0.66
0.01
(1.54%)
Fuera de horario: 5:59PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
0.66
Postura de Compra
0.585
Postura de Venta
0.7999
Volume Operado de la Acción
142,784,202
0.5827 Rango del Día 0.8701
0.1412 Rango de 52 semanas 2.06
Capitalización de Mercado [m]
Precio Anterior
0.576
Precio de Apertura
0.6062
Última hora de negociación
Volumen financiero
US$ 99,333,170
Precio Promedio Ponderado
0.695687
Volumen promedio (3 m)
24,018,402
Acciones en circulación
8,471,172
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-10.69
Beneficio por acción (BPA)
-1.25
turnover
2.23M
Beneficio neto
-10.63M

Acerca de Ensysce Biosciences Inc

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provid... Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
New York, New York, USA
Fundado
-
Ensysce Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENSC. The last closing price for Ensysce Biosciences was US$0.58. Over the last year, Ensysce Biosciences shares have traded in a share price range of US$ 0.1412 to US$ 2.06.

Ensysce Biosciences currently has 8,471,172 shares in issue. The market capitalisation of Ensysce Biosciences is US$4.88 million. Ensysce Biosciences has a price to earnings ratio (PE ratio) of -10.69.

ENSC Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.3349103.014457090.32510.77890.31063606990.61986561CS
40.428184.4827586210.2320.82160.1412652052130.56379838CS
120.2978.37837837840.370.82160.1412240184020.56747868CS
260.068411.56186612580.59160.82160.1412111437380.56732859CS
52-0.284-30.08474576270.9442.060.141260756420.62027301CS
156-527.34-99.87552816800.14123332266195.06254338CS
260-3824.94-99.98274780433825.64108.80.14123151289233.641651CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
VSTEVast Renewable Ltd
US$ 4.98
(149.00%)
68.54M
INVZWInnoviz Technologies Ltd
US$ 0.096
(96.71%)
22.71k
CDXCChromaDex Corporation
US$ 5.87
(68.19%)
37.88M
ATHAAthira Pharma Inc
US$ 0.606
(41.56%)
239.63M
TILEInterface Inc
US$ 23.24
(33.03%)
2.16M
EPIXESSA Pharma Inc
US$ 1.45
(-72.12%)
34.3M
ELABElevai Labs Inc
US$ 0.0288
(-51.19%)
202.28M
OSTOstin Technology Group Company Ltd
US$ 0.275
(-45.00%)
2.27M
LXRXLexicon Pharmaceuticals Inc
US$ 1.23
(-36.92%)
21M
VCIGVCI Global Ltd
US$ 0.0583
(-27.58%)
26.57M
ATHAAthira Pharma Inc
US$ 0.606
(41.56%)
239.63M
SQQQProShares UltraPro Short QQQ
US$ 7.44
(-2.11%)
216.16M
NVDANVIDIA Corporation
US$ 135.40
(1.99%)
209.27M
ELABElevai Labs Inc
US$ 0.0288
(-51.19%)
202.28M
INTCIntel Corporation
US$ 23.20
(7.81%)
173.47M

ENSC Discussion

Ver más
BeeHaus2 BeeHaus2 2 días hace
Another solid day on good volume. Need to get through the .80s and test 1.00 next week.
👍️0
glenn1919 glenn1919 2 días hace
ENSC............................................https://stockcharts.com/h-sc/ui?s=ENSC&p=W&b=5&g=0&id=p86431144783
👍️0
INV4 INV4 2 días hace
ENSC looking good 😃

GLTA $ENSC
👍️0
shrinknp shrinknp 2 días hace
The interest rate for ENSC loaned securities is 104%. Can someone explain to me the ludicrousness of this?
👍️0
BeeHaus2 BeeHaus2 2 días hace
Time for the move above $1
👍️ 1 🚀 1
INV4 INV4 4 días hace
Bought some ENSC this morning!

$ENSC
👍️0
madras50 madras50 4 días hace
somehow i doubt that
👍️0
PirateLeviathan8 PirateLeviathan8 4 días hace
ENSC the next DRUG
👍️0
PirateLeviathan8 PirateLeviathan8 4 días hace
ENSC go to the moon
👍️0
glenn1919 glenn1919 4 días hace
ENSC...................................https://stockcharts.com/h-sc/ui?s=ENSC&p=W&b=5&g=0&id=p86431144783
👍️0
BeeHaus2 BeeHaus2 4 días hace
A similar run here is possible.
👍️0
tw0122 tw0122 5 días hace
.58 + 40%
👍️0
bigrun bigrun 5 días hace
Hi, why is this ticker making big gains?
👍️0
Shift-4 Shift-4 5 días hace
The hedge that bought 430k shares of DRUG two weeks ago on the day it started running from $3 to $108 within 4 days -- they just disclosed buying in for 1.3M shares at ENSC.

https://www.otcmarkets.com/filing/html?id=17924517&guid=CHL-kp-Ja1ZuB3h

-$
👍️ 1
BeeHaus2 BeeHaus2 5 días hace
Another nice move on heavy volume.
👍️0
glenn1919 glenn1919 5 días hace
ENSC..........................https://stockcharts.com/h-sc/ui?s=ENSC&p=W&b=5&g=0&id=p86431144783
👍️0
BooDog BooDog 1 semana hace
After reading this from the company I'd think it's a matter of wheather or not Nasdaq will grant another 180 days after meeting their equity requirement. Possibly why this gapped up the other day.

What is the latest update from the Company in terms of Nasdaq listing requirements?

As of September 30, 2024, we believe we are in compliance with Nasdaq requirements regarding stockholders' equity and we are looking forward to the upcoming hearing with Nasdaq to discuss our plans to continue to maintain compliance with both the stockholders' equity requirement and the $1.00 bid price requirement.
https://finance.yahoo.com/news/ensysce-biosciences-provides-shareholder-responds-120000514.html

SAN DIEGO, CA / ACCESSWIRE / September 27, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, has received notice from the listing qualifications department staff of The Nasdaq Stock Market ("Nasdaq") stating that the Company has not regained compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price for the Company's common stock has remained below $1.00 per share through the initial 180-day compliance period ended September 23, 2024. The Company is not eligible for a second 180-day period because it does not comply with the minimum stockholders' equity requirement for initial listing on The Nasdaq Capital Market. The Nasdaq Hearings Panel will consider this matter in rendering a determination regarding the Company's continued listing on The Nasdaq Capital Market at an upcoming hearing which will also consider the Company's non-compliance with the $2.5 million stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1).
https://www.accesswire.com/924643/ensysce-biosciences-receives-notice-from-nasdaq

This caught my eye this morning with the PM volume.
👍️0
frankyahoo frankyahoo 2 semanas hace
Today's volume was amazing. They came for it. Not sure it will be a multi day move but today was a good day.
👍️0
Mr. Zen Mr. Zen 2 semanas hace
thanks, I'll take that as a compliment.
👍️0
TheFinalCD TheFinalCD 2 semanas hace
new highs on massive volume
👍️0
TheFinalCD TheFinalCD 2 semanas hace
THAT VOLUME
👍️0
Invest-in-America Invest-in-America 2 semanas hace
ENSC: Below is COPILOT's answer just now to my question about ENSC.
https://copilot.microsoft.com/?FORM=hpcodx&showconv=1
👍️0
TheFinalCD TheFinalCD 2 semanas hace
so easy even a caveman can do it
👍️0
Invest-in-America Invest-in-America 2 semanas hace
ENSC: "DILUTION HITTING HARD"??? (Heck, looks more like PROFITS HITTING HARD, for anybody in here.)
👍️0
Mr. Zen Mr. Zen 2 semanas hace
Top gainer, here we go (eom)
👍️0
TheFinalCD TheFinalCD 2 semanas hace
.444
👍️0
tw0122 tw0122 2 semanas hace
.47 Hey always the next one.. The A-3 warrants and A-4 warrants cover up to 14.4 million shares each with an exercise price of $0.47 per share, while up to 752,969 shares are issuable under the placement warrants, according to the filing.

The exercise of the warrants is conditional on shareholders' approval, the company added.

Ensysce said it will not receive any proceeds from the sale of shares by selling stockholders but will get proceeds from the exercise of warrants that will be used for working capital for general corporate purposes.

Shares of the company rose 2.8% in after-hours
👍️0
TheFinalCD TheFinalCD 2 semanas hace
shoulda coulda bought more

ensc pic.twitter.com/uxbDHxgQtO— THE FINAL COUNTDOWN (@READY_2_PROFIT) October 22, 2024
👍️0
TrendTrade2016 TrendTrade2016 2 semanas hace
DILUTION HITTING HARD
👍 1
frankyahoo frankyahoo 2 semanas hace
I think the SEC filings that dropped show that they are taking the steps needed to regain compliance. Markets liked it.

Who knows?
 
$ENSC
👍️0
glenn1919 glenn1919 2 semanas hace
ENSC................................https://stockcharts.com/h-sc/ui?s=ENSC&p=W&b=5&g=0&id=p86431144783
👍️0
twitchy twitchy 2 semanas hace
What's up with the spike in volume today?
👍️0
twitchy twitchy 2 semanas hace
What's the consensus on a reverse split these days? I'd love to average down, but I keep getting burned!
👍️0
BeeHaus2 BeeHaus2 3 semanas hace
Btw, if anyone is paying attention. Look at the 5yr chart. This might be the greatest short position in history.
👍️0
BeeHaus2 BeeHaus2 3 semanas hace
Good volume. Hopefully this is the reversal.
👍 2
BeeHaus2 BeeHaus2 4 semanas hace
Continuing the downward trend...ugh
👍️0
BeeHaus2 BeeHaus2 1 mes hace
These are options for the executives to buy. After doing an offering and crushing the stock after the grant.
I'm still holding but this is not shareholder friendly activity.

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests o Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
👍️0
BeeHaus2 BeeHaus2 1 mes hace
It looks like this is an offering not an investment by the executives.
Not that changes the narrative that they would not want to reverse split their warrants or new shares but it does not look like they are investing their own cash.
Let me know if I'm reading it wrong.
👍️0
twitchy twitchy 1 mes hace
Very interesting. Thank you for the information.
👍️0
Shift-4 Shift-4 1 mes hace
Yes. Between the initial equity investment and this, insiders have bought >70% of the fully diluted OS:

https://www.otcmarkets.com/filing/html?id=17831496&guid=h5L-kHuX-EcpJth

Possibly more after today, given premarket activity. Form 4s will hit after hours or tomorrow if that's the case.

Regardless, they didn't invest $7m out of pocket to rs on themselves.

-$
👍️0
twitchy twitchy 1 mes hace
Betting against another reverse split?
👍️0
Shift-4 Shift-4 1 mes hace
I'm loading up.

-$
👍️0
Monksdream Monksdream 1 mes hace
ENSC new 52 week low
👍️0
twitchy twitchy 1 mes hace
It sure would be nice to see this finally turn around!
👍️0
BeeHaus2 BeeHaus2 1 mes hace
Not sure where the bottom is here. I'll wait longer...
👍️0
Shift-4 Shift-4 1 mes hace
Phase 3 news- nice. Looks like it'll be relatively inexpensive, and using the 505(b)2 approval pathway, this is likely the only phase 3 data they need to obtain approval.

The volume spike without a massive % shift is encouraging- less likely that scalpers will P&D it. If the direct offering was to non-vultures, this could be the start of a sustained revaluation.

-$
👍️0
Monksdream Monksdream 2 meses hace
ENSC new 52=week low
👍️0
twitchy twitchy 2 meses hace
Another RS is definitely a huge concern. I thought they were finally going to move it up after those two press releases in one day, so I averaged down... for the third time. Then they announce the offering. Maybe they're planning something, but that seemed to be one of the dumbest moves I've seen with this stock. It's been really frustrating here!
👍️0
BeeHaus2 BeeHaus2 2 meses hace
I'm planning to avg down at some point soon.
Just not sure when. I'm concerned about another RS to stay compliant on Nasdaq.
👍️0
twitchy twitchy 2 meses hace
Pretty pissed off indeed. It's brutal. Hopefully something good happens one of these days, and my average isn't too high to get out with a marginal loss!
👍️0

Su Consulta Reciente

Delayed Upgrade Clock